(IMAGE)
Caption
The industry continues to step up its efforts to improve access to medicine in developing countries. GSK tops the Index for the fourth time, followed closely by Novo Nordisk and a cluster of companies in 3rd, 4th, 5th and 6th place.
Credit
© Access to Medicine Foundation
Usage Restrictions
Always give the source as 2014 Access to Medicine Index
License
Licensed content